NEXGEL, INC. (NXGL): Nasdaq/NYSE listing notice — NexGel receives Nasdaq deficiency notice for bid price below $1; 180 days to cure

NEXGEL, INC.

Closing bid price of common stock (NXGL) below $1.00 for 30 consecutive business days.
Company has until October 19, 2026 to regain compliance per Nasdaq Rule 5810(c)(3)(A).
Compliance possible if bid price closes at $1.00+ for 10 consecutive days before deadline.
If not cured, a second 180-day compliance period may be available subject to conditions.
Company may consider a reverse stock split; no assurance of regaining compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

NEXGEL, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

April 22, 2026, NexGel, Inc. (the “ Company ”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for th

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

NEXGEL, INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-018962

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.